Atreya, Raja

Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo

Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine

Inflammatory Bowel DiseaseCytokine Signaling Pathways and Interactions

Cited by 1,293

CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes

Tiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H. A., Wirtz, S., Becker, C., Atreya, R., et al. (2003) · Journal of Clinical Investigation

Protein Kinase Regulation and GTPase SignalingCell death mechanisms and regulation

Cited by 828

TH9 cells that express the transcription factor PU.1 drive T cell–mediated colitis via IL-9 receptor signaling in intestinal epithelial cells

Gerlach, K., Hwang, Y., Nikolaev, A., Atreya, R., Dornhoff, H., Steiner, S., Lehr, H.-A., Wirtz, S., Vieth, M., Waisman, A., et al. (2014) · Nature Immunology

Inflammatory Bowel DiseaseT-cell and B-cell Immunology

Cited by 407

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease

Atreya, R., Neumann, H., Neufert, C., Waldner, M. J., Billmeier, U., Zopf, Y., Willma, M., App, C., Münster, T., Kessler, H., et al. (2014) · Nature Medicine

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies

Cited by 392

Involvement of IL–6 in the pathogenesis of inflammatory bowel disease and colon cancer

Atreya, R., & Neurath, M. F. (2005) · Clinical Reviews in Allergy & Immunology

Inflammatory Bowel DiseaseCytokine Signaling Pathways and Interactions

Cited by 324

Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases

Ruder, B., Atreya, R., & Becker, C. (2019) · International Journal of Molecular Sciences

Inflammatory Bowel DiseaseNF-κB Signaling Pathways

Cited by 228

IL-9 and its receptor are predominantly involved in the pathogenesis of UC

Nalleweg, N., Chiriac, M. T., Podstawa, E., Lehmann, C., Rau, T. T., Atreya, R., Krauss, E., Hundorfean, G., Fichtner-Feigl, S., Hartmann, A., et al. (2015) · Gut

Inflammatory Bowel DiseasePsoriasis: Treatment and Pathogenesis

Cited by 181

Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in inflammatory bowel disease: the prospective ERIca trial

Rath, T., Atreya, R., Bodenschatz, J., Uter, W., Geppert, C. E., Vitali, F., Fischer, S., Waldner, M. J., Colombel, J.-F., Hartmann, A., et al. (2023) · Gastroenterology

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 133

Molecular imaging of mucosal α4β7 integrin expression with the fluorescent anti-adhesion antibody vedolizumab in Crohn's disease

Rath, T., Bojarski, C., Neurath, M. F., & Atreya, R. (2017) · Gastrointestinal Endoscopy

Inflammatory Bowel DiseaseCell Adhesion Molecules Research

Cited by 83

PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells

Gerlach, K., Popp, V., Wirtz, S., Al-Saifi, R., Gonzalez Acera, M., Atreya, R., Dregelies, T., Vieth, M., Fichtner-Feigl, S., McKenzie, A. N. J., et al. (2022) · Journal of Crohn's and Colitis

T-cell and B-cell ImmunologyIL-33, ST2, and ILC Pathways

Cited by 25